Rationale of Earlier AS Treatment: Asymptomatic Severe AS and Moderate AS

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Grant Support/Research Contract (Institutional) - Abbott Vascular; Medtronic; Boston Scientific Corporation; PulseCath BV; Biotronik; Edwards Lifesciences; Abiomed
• Consultant Fee/Honoraria/Speaker's Bureau (Institutional) - Boston Scientific Corporation
• Grant Support/Research Contract (Both) - Daiichi-Sankyo/Elil Lilly and Company